ResearcherAmsterdam UMC Location University of AmsterdamNo recent work listed
E. Lens
Matched on ORCID iD 0000-0001-7364-9714; OpenAlex author ID A5016784441. Sources: OpenAlex.
Their work
- Papers
- 7 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 15
2014: 2 papers · 2015: 2 papers · 2016: none · 2017: 3 papers
Papers 7
- Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The dummy run. First author DOI 10.1007/s00066-017-1153-6↗
- Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows only limited dosimetric benefit. Co-author DOI 10.1080/0284186x.2016.1257863↗
- Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study. Co-author DOI 10.1186/s13014-017-0777-0↗
- Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer. Co-author DOI 10.1016/j.ijrobp.2015.02.015↗
- Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. First author DOI 10.1118/1.4918753↗
- EUS-guided fiducial markers placement with a 22-gauge needle for image-guided radiation therapy in pancreatic cancer. Co-author DOI 10.1016/j.gie.2013.12.027↗
- Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials compared. First author DOI 10.1016/j.ijrobp.2014.03.029↗
Closest collaborators
The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Astrid van der Horst · 7 shared papers, 2014–2017 · strength 0.41
- Paper Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The … DOI 10.1007/s00066-017-1153-6↗
- Paper Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows… DOI 10.1080/0284186x.2016.1257863↗
- Paper Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer. DOI 10.1016/j.ijrobp.2015.02.015↗
- Arjan Bel · 7 shared papers, 2014–2017 · strength 0.41
- Paper Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The … DOI 10.1007/s00066-017-1153-6↗
- Paper Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows… DOI 10.1080/0284186x.2016.1257863↗
- Paper Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer. DOI 10.1016/j.ijrobp.2015.02.015↗
- Geertjan van Tienhoven · 6 shared papers, 2014–2017 · strength 0.36
- Paper Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The … DOI 10.1007/s00066-017-1153-6↗
- Paper Probabilistic treatment planning for pancreatic cancer treatment: prospective incorporation of respiratory motion shows… DOI 10.1080/0284186x.2016.1257863↗
- Paper Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer. DOI 10.1016/j.ijrobp.2015.02.015↗
- Eva Versteijne · 3 shared papers, 2015–2017 · strength 0.20
- Paper Quality assurance of the PREOPANC trial (2012-003181-40) for preoperative radiochemotherapy in pancreatic cancer : The … DOI 10.1007/s00066-017-1153-6↗
- Paper Dosimetric Advantages of Midventilation Compared With Internal Target Volume for Radiation Therapy of Pancreatic Cancer. DOI 10.1016/j.ijrobp.2015.02.015↗
- Paper Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study. DOI 10.1186/s13014-017-0777-0↗
- Jeanin Elise van Hooft · 3 shared papers, 2014–2015 · strength 0.14
- Paper Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. DOI 10.1118/1.4918753↗
- Paper Limited role for biliary stent as surrogate fiducial marker in pancreatic cancer: stent and intratumoral fiducials comp… DOI 10.1016/j.ijrobp.2014.03.029↗
- Paper EUS-guided fiducial markers placement with a 22-gauge needle for image-guided radiation therapy in pancreatic cancer. DOI 10.1016/j.gie.2013.12.027↗
- Oliver J. Gurney‐Champion · 2 shared papers, 2015–2017 · strength 0.11
- Paper Considerable interobserver variation in delineation of pancreatic cancer on 3DCT and 4DCT: a multi-institutional study. DOI 10.1186/s13014-017-0777-0↗
- Paper Visibility and artifacts of gold fiducial markers used for image guided radiation therapy of pancreatic cancer on MRI. DOI 10.1118/1.4918753↗
- Hanne D. Heerkens · 1 shared paper, 2017 · strength 0.07
- Gert J. Meijer · 1 shared paper, 2017 · strength 0.07
- Mustafa Suker · 1 shared paper, 2017 · strength 0.07
- Casper H.J. van Eijck · 1 shared paper, 2017 · strength 0.07
- G. Ebrahimi · 1 shared paper, 2017 · strength 0.06
- Antonetta C. Houweling · 1 shared paper, 2015 · strength 0.05
- Remy Klaassen · 1 shared paper, 2015 · strength 0.05
- Aart Johannes Nederveen · 1 shared paper, 2015 · strength 0.05
- Raquel Dávila Fajardo · 1 shared paper, 2014 · strength 0.04
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.